-
Je něco špatně v tomto záznamu ?
Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat
A Jansson, T Mazel, B Andbjer, L Rosen, D Guidolin, M Zoli, E Sykova, LF Agnati, K Fuxe
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem
Grantová podpora
IZ3423
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
PubMed
10336061
Knihovny.cz E-zdroje
- MeSH
- biotin analogy a deriváty aplikace a dávkování farmakokinetika MeSH
- časové faktory MeSH
- dextrany aplikace a dávkování farmakokinetika MeSH
- difuze MeSH
- extracelulární prostor enzymologie metabolismus účinky léků MeSH
- fluorescenční barviva MeSH
- gangliová stimulancia diagnostické užití MeSH
- hematoencefalická bariéra účinky léků MeSH
- indazoly farmakologie MeSH
- inhibitory enzymů * farmakologie MeSH
- krysa rodu rattus MeSH
- kvartérní amoniové sloučeniny diagnostické užití MeSH
- mozkový krevní oběh účinky léků MeSH
- neostriatum * enzymologie účinky léků ultrastruktura MeSH
- NG-nitroargininmethylester farmakologie MeSH
- počítačové zpracování obrazu MeSH
- potkani Sprague-Dawley MeSH
- proteiny nervové tkáně metabolismus MeSH
- synthasa oxidu dusnatého, typ I MeSH
- synthasa oxidu dusnatého * antagonisté a inhibitory metabolismus MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
Volume transmission in the brain is mediated by the diffusion of neurotransmitters, modulators and other neuroactive substances in the extracellular space. The effects of nitric oxide synthase inhibition on extracellular space diffusion properties were studied using two different approaches, the histological dextran method and the real-time iontophoretic tetramethylammonium method. The spread of biotinylated dextran (mol. wt 3000) in the extracellular space was measured morphometrically following microinjection into the neostriatum of male rats. Two parameters were used to describe the spread of biotinylated dextran in brain tissue, namely, total volume of spread and the mean grey value. The nonspecific nitric oxide synthase inhibitors NG-nitro-L-arginine methyl ester (10-100 mg/kg) and NG-monomethyl-L-arginine acetate (30-200 mg/kg) decreased the total volume of spread of dextran in a dose-dependent manner. 7-Nitroindazole monosodium salt (50-100 mg/kg), a specific neuronal nitric oxide synthase inhibitor, did not change the total volume of spread of dextran. Using the tetramethylammonium method, the extracellular space diffusion properties can be described by the volume fraction (alpha = extracellular space volume/total tissue volume), tortuosity lambda (lambda2 = free diffusion coefficient/apparent diffusion coefficient in tissue), and non-specific uptake kappa' [Nicholson C. and Sykova E. (1998) Trends Neurosci. 21, 207-215]. Nitric oxide synthase inhibition by NG-nitro-L-arginine methyl ester (50 mg/kg) had relatively little effect on volume fraction and tortuosity, and no changes were observed after NG-monomethyl-L-arginine acetate (20 mg/kg) or 7-nitroindazole monosodium salt (100 mg/kg) treatment. A substantial increase was found only in non-specific uptake, by 13% after NG-nitro-L-arginine methyl ester and by 16% after NG-monomethyl-L-arginine acetate, which correlates with the decreased total volume of spread of dextran observed with the dextran method. NG-Nitro-L-arginine methyl ester treatment (100 mg/kg) decreased striatal blood flow and increased mean arterial blood pressure. The changes in dextran spread and non-specific uptake can be explained by an increased capillary clearance following the inhibition of endothelial nitric oxide synthase, as neuronal nitric oxide synthase inhibition had no effect. The observed changes after non-specific nitric oxide synthase inhibition may affect the extracellular space concentration of neurotransmitters and modulators, and influence volume transmission pathways in the central nervous system by increased capillary and/or cellular clearance rather than by changes in extracellular space diffusion.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14055960
- 003
- CZ-PrNML
- 005
- 20241204114030.0
- 007
- ta
- 008
- 140414s1999 xxu f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)10336061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jansson, A. $u Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
- 245 10
- $a Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat / $c A Jansson, T Mazel, B Andbjer, L Rosen, D Guidolin, M Zoli, E Sykova, LF Agnati, K Fuxe
- 520 9_
- $a Volume transmission in the brain is mediated by the diffusion of neurotransmitters, modulators and other neuroactive substances in the extracellular space. The effects of nitric oxide synthase inhibition on extracellular space diffusion properties were studied using two different approaches, the histological dextran method and the real-time iontophoretic tetramethylammonium method. The spread of biotinylated dextran (mol. wt 3000) in the extracellular space was measured morphometrically following microinjection into the neostriatum of male rats. Two parameters were used to describe the spread of biotinylated dextran in brain tissue, namely, total volume of spread and the mean grey value. The nonspecific nitric oxide synthase inhibitors NG-nitro-L-arginine methyl ester (10-100 mg/kg) and NG-monomethyl-L-arginine acetate (30-200 mg/kg) decreased the total volume of spread of dextran in a dose-dependent manner. 7-Nitroindazole monosodium salt (50-100 mg/kg), a specific neuronal nitric oxide synthase inhibitor, did not change the total volume of spread of dextran. Using the tetramethylammonium method, the extracellular space diffusion properties can be described by the volume fraction (alpha = extracellular space volume/total tissue volume), tortuosity lambda (lambda2 = free diffusion coefficient/apparent diffusion coefficient in tissue), and non-specific uptake kappa' [Nicholson C. and Sykova E. (1998) Trends Neurosci. 21, 207-215]. Nitric oxide synthase inhibition by NG-nitro-L-arginine methyl ester (50 mg/kg) had relatively little effect on volume fraction and tortuosity, and no changes were observed after NG-monomethyl-L-arginine acetate (20 mg/kg) or 7-nitroindazole monosodium salt (100 mg/kg) treatment. A substantial increase was found only in non-specific uptake, by 13% after NG-nitro-L-arginine methyl ester and by 16% after NG-monomethyl-L-arginine acetate, which correlates with the decreased total volume of spread of dextran observed with the dextran method. NG-Nitro-L-arginine methyl ester treatment (100 mg/kg) decreased striatal blood flow and increased mean arterial blood pressure. The changes in dextran spread and non-specific uptake can be explained by an increased capillary clearance following the inhibition of endothelial nitric oxide synthase, as neuronal nitric oxide synthase inhibition had no effect. The observed changes after non-specific nitric oxide synthase inhibition may affect the extracellular space concentration of neurotransmitters and modulators, and influence volume transmission pathways in the central nervous system by increased capillary and/or cellular clearance rather than by changes in extracellular space diffusion.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a biotin $x analogy a deriváty $x aplikace a dávkování $x farmakokinetika $7 D001710
- 650 02
- $a hematoencefalická bariéra $x účinky léků $7 D001812
- 650 02
- $a mozkový krevní oběh $x účinky léků $7 D002560
- 650 02
- $a dextrany $x aplikace a dávkování $x farmakokinetika $7 D003911
- 650 02
- $a difuze $7 D004058
- 650 02
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 12
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 02
- $a extracelulární prostor $x enzymologie $x metabolismus $x účinky léků $7 D005110
- 650 02
- $a fluorescenční barviva $7 D005456
- 650 02
- $a gangliová stimulancia $x diagnostické užití $7 D005731
- 650 02
- $a počítačové zpracování obrazu $7 D007091
- 650 02
- $a indazoly $x farmakologie $7 D007191
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a NG-nitroargininmethylester $x farmakologie $7 D019331
- 650 12
- $a neostriatum $x enzymologie $x účinky léků $x ultrastruktura $7 D017072
- 650 02
- $a proteiny nervové tkáně $x metabolismus $7 D009419
- 650 12
- $a synthasa oxidu dusnatého $x antagonisté a inhibitory $x metabolismus $7 D019001
- 650 02
- $a synthasa oxidu dusnatého, typ I $7 D052248
- 650 02
- $a kvartérní amoniové sloučeniny $x diagnostické užití $7 D000644
- 650 02
- $a krysa rodu Rattus $7 D051381
- 650 02
- $a potkani Sprague-Dawley $7 D017207
- 650 02
- $a časové faktory $7 D013997
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mazel, Tomáš $7 xx0086098
- 700 1_
- $a Andbjer, B. $7 gn_A_00005934
- 700 1_
- $a Rosen, L.
- 700 1_
- $a Guidolin, D.
- 700 1_
- $a Zoli, M.
- 700 1_
- $a Syková, Eva, $d 1944- $7 jn20000710633
- 700 1_
- $a Agnati, L.F. $7 gn_A_00002193
- 700 1_
- $a Fuxe, Kjell, $d 1938- $7 mzk20231210633
- 773 0_
- $t Neuroscience $x 0306-4522 $g Roč. 91, č. 1 (1999), s. 69-80 $p Neuroscience $w MED00003505
- 910 __
- $a ABA008 $b B 1931 $y 4 $z 0
- 990 __
- $a 20140414092237 $b ABA008
- 991 __
- $a 20241204114025 $b ABA008
- 999 __
- $a ok $b bmc $g 1019553 $s 854552
- BAS __
- $a 3
- BMC __
- $a 1999 $b 91 $c 1 $d 69-80 $x MED00003505 $i 0306-4522 $m Neuroscience $n Neuroscience
- GRA __
- $a IZ3423 $p MZ0
- LZP __
- $a NLK 2014-04/lpbo